Summary
CME Group Inc. reported solid revenue growth for the nine months ended September 30, 2022, with total revenues increasing by 8% to $3.81 billion, driven primarily by a 12% rise in clearing and transaction fees. This growth was supported by a significant 23% increase in total contract volume, reflecting heightened market volatility in interest rate and equity index products due to inflation concerns and Federal Reserve policy shifts. While revenue grew, total expenses saw a decrease of 4% year-over-year, leading to an improved operating margin of 61.6% for the nine-month period. Despite a substantial decrease in non-operating income, primarily due to a lower net gain from the OSTTRA joint venture in the prior year and increased expenses related to interest distribution on performance bond collateral, net income attributable to CME Group remained relatively stable at $2.05 billion for the nine months ended September 30, 2022, a slight increase of 2% compared to the prior year. Diluted earnings per share also saw a modest increase. The company's financial position remains strong, with significant liquidity and robust capital resources, including a substantial amount of cash and cash equivalents and undrawn credit facilities.
Financial Highlights
45 data points| Revenue | $1.23B |
| Operating Expenses | $489.00M |
| Operating Income | $738.80M |
| Net Income | $679.60M |
| EPS (Basic) | $1.87 |
| EPS (Diluted) | $1.87 |
| Shares Outstanding (Basic) | 358.71M |
| Shares Outstanding (Diluted) | 359.29M |
Key Highlights
- 1Total revenues increased by 8% to $3.81 billion for the first nine months of 2022, driven by a 12% increase in clearing and transaction fees.
- 2Total contract volume rose by 23% for the first nine months of 2022, with notable growth in interest rate (24%) and equity index (44%) products, reflecting increased market volatility.
- 3Total expenses decreased by 4% for the first nine months of 2022 due to lower compensation and benefits, professional fees, and other operating costs.
- 4Net income attributable to CME Group increased by 2% to $2.05 billion for the first nine months of 2022.
- 5Diluted earnings per share increased slightly to $5.64 for the first nine months of 2022.
- 6Cash flow from operating activities increased by 20% to $2.07 billion for the first nine months of 2022.
- 7The company maintained strong liquidity with $2.1 billion in cash and cash equivalents and significant access to revolving credit facilities totaling $9.3 billion.